NCT02699125View on ClinicalTrials.gov

Treatment of OSA Associated Hypertension With Alpha 2 Agonist or Diuretic

PHASE4CompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

June 30, 2016

Study Completion Date

August 31, 2016

Conditions
Obstructive Sleep Apnea
Interventions
DRUG

Guanfacine

Guanfacine 1mg for 2 weeks followed by guanfacine 2mg for 4 weeks.

DRUG

Hydrochlorothiazide

Hydrochlorothiazide 12.5 mg for 2 weeks followed by hydrochlorothiazide 25 mg for 4 weeks

All Listed Sponsors
lead

University of California, San Diego

OTHER

NCT02699125 - Treatment of OSA Associated Hypertension With Alpha 2 Agonist or Diuretic | Biotech Hunter | Biotech Hunter